TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Frontage Holdings Corp. ( (HK:1521) ) has issued an update.
Frontage Holdings Corporation has announced a leadership change effective January 6, 2025, where Dr. Abdul Mutlib will step down as CEO and transition to an advisory role, while Dr. Wentao Zhang and Dr. Zhongping Lin are appointed as Co-CEOs. This strategic move is part of the company’s leadership succession plan, aimed at ensuring continuity and fostering growth, with Dr. Mutlib continuing to support the company in an advisory capacity.
More about Frontage Holdings Corp.
Frontage Holdings Corporation, incorporated in the Cayman Islands, operates in the biotechnology and pharmaceutical industry, providing drug discovery and development services through its subsidiaries, including Frontage Laboratories, Inc.
YTD Price Performance: -11.24%
Average Trading Volume: 3,017,969
Technical Sentiment Consensus Rating: Sell
Current Market Cap: HK$3.22B
See more data about 1521 stock on TipRanks’ Stock Analysis page.